Welcome to eBioscience. Tel: 888.999.1371 or 858.642.2058.  San Diego, California, USA.
View cart
Account
Ordering help
MSDS
Home BestProtocols™ Technical Support About Us Contact Us
Clinical Products Research Products Custom Products Weekly New Products

Choose language for TDS:
 

Alexa FluorŽ 647 anti-mouse Granzyme B

RUO: For Research Use Only
 
Contents: Alexa FluorŽ 647 anti-mouse Granzyme B
Catalog Number: 51-8822
Formulation: Phosphate buffered saline, pH 7.2, less than or equal to 0.09% NaN3, BSA and/or gelatin for protein stabilization
Clone: 16G6
Host/Isotype: Rat IgG2b, κ
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
LIGHT-SENSITIVE MATERIAL.
 
Product Options
Cat. No. Size Price Add Qty to Cart
51-8822-80 25 ug
To view relevant pricing, please select your country and resume browsing.

Note: Several countries will continue to be supplied via distributors. Country specific prices may apply.
 
Research Related Products
Cat. No.Format
51-4031 Alexa FluorŽ 647 Rat IgG2b Isotype Control
 

Available Formats
Cat. No.FormatExcite
(nm)
Emit
(nm)
Reported ApplicationsRegulatory Status
11-8822 Fluorescein isothiocyanate (FITC) anti-mouse Granzyme B 488 518 IC Flow RUO
12-8822 Phycoerythrin (PE) anti-mouse Granzyme B 488 575 IC Flow RUO
13-8822 Biotin anti-mouse Granzyme B N/A N/A IC Flow WB RUO
14-8822 Affinity Purified anti-mouse Granzyme B N/A N/A ELISA cap WB RUO
25-8822 Phycoerythrin-Cy7 (PE-Cy7) anti-mouse Granzyme B 488 760 IC Flow RUO
51-8822 Alexa Fluor® 647 anti-mouse Granzyme B 633 668 IC Flow RUO
Flow Cytometry Product Notes:
Test Sizes: To accommodate multicolor flow cytometry, eBioscience is in the process of reducing test size volumes from 20 µl to 5 µl. Please check your antibody vial for the recommended test size.
Fluorochrome Replacements: eBioscience is in the process of replacing all Pacific Blue® and APC-Alexa Fluor® 750 conjugated products with eFluor™ 450 and APC-eFluor™ 780 conjugated products, respectively.
 
Description
The 16G6 antibody reacts with mouse Granzyme B (GrB) which is a member of the granzyme serine protease family. GrB is found in the granules of cytotoxic T cells and NK cells. Granzyme B has also been described as CGL1 (cathepsin G-like-1), a serine protease expressed only in cytotoxic T-lymphocytes after cell activation. GrB has been called CTLA-1 (cytotoxic T lymphocyte-associated serine esterase 1) based on identification of mRNA in various cytotoxic T cells, but not observed in non-cytotoxic lymphoid cells. GrB is crucial for the rapid induction of target cell death by apoptosis, induced by interaction with cytotoxic T cells. The receptor involved has been identified as mannose 6-phosphate receptor. This receptor functions as a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

For intracellular staining and flow cytometric analysis with direct conjugates of anti-mouse Granzyme B, it is highly recommended to use the Foxp3 Staining Buffer Set (cat. 00-5523). Other buffers may yield varying results. For more information, please contact technical support at tech@ebioscience.com.
Applications Reported
For research use only, not for diagnostic or therapeutic use. This 16G6 antibody has been reported for use in intracellular staining followed by flow cytometric analysis.
Applications Tested
This 16G6 antibody has been tested by intracellular staining and flow cytometric analysis of paraformaldehyde-fixed/saponin-permeabilized IL-2 stimulated splenocytes. This can be used at less than or equal to 0.125 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
References
Akha AA, Berger SB, Miller RA. Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice. Immunology. 2006 Oct;119(2):187-94. (16G6, Intracellular Flow, PubMed)

Kapp JA, Honjo K, Kapp LM, Xu XY, Cozier A, Bucy RP. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int Immunol. 2006; 1-14. (16G6, IC flow, PubMed)

Kilinc MO, Aulakh KS, Nair RE, Jones SA, Alard P, Kosiewicz MM, Egilmez NK. Reversing Tumor Immune Suppression with Intratumoral IL-12: Activation of Tumor-Associated T Effector/Memory Cells, Induction of T Suppressor Apoptosis, and Infiltration of CD8+ T Effectors. J Immunol. 2006 Nov 15;177(10):6962-73 (16G6, IC Flow, PubMed)

Smyth, M., et al. 1995. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today. 16: 202-206.

Shafer-Weaver, K., et al. 2003. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J. Translational Med. 1: 14.

Rininsland, F., et al. 2000. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Meth. 240:143-155.
Legal
Alexa FluorŽ and Pacific BlueŽ are registered trademarks of and licensed under patents assigned to Molecular Probes, Inc. for research use only. This product is subject to an agreement between Molecular Probes, Inc. and eBioscience, and the manufacture, use, sale or import of this product may be subject to one or more U.S. patents, pending applications and corresponding foreign equivalents, owned by Molecular Probes, Inc. (a wholly owned subsidiary of Invitrogen Corp). The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product for life science research or as an ASR. The buyer cannot use this product for manufacturing or for any other screening (specifically including use in combination with microarrays or High Content Screening) or testing purpose, other than as an ASR. For information on purchasing a license to this product for purposes other than life science research or use as an ASR, contact Molecular Probes, Inc.

Home  |   Index  |   Site Map  |   FAQ  |   Terms & Conditions  |   Distributors  |   Careers  |   Contact Us
Copyright © 2000-2009 eBioscience, Inc.
For research use only unless indicated otherwise. Not for further distribution without written consent.